Eriksson, B., Dahl, O. E., Rosencher, N., Clemens, A., Hantel, S., Feuring, M., . . . Friedman, R. J. (2015). Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: Pooled analysis of two phase 3 randomized trials. Thrombosis journal, 13, . https://doi.org/10.1186/s12959-015-0067-8
Chicago-Zitierstil (17. Ausg.)Eriksson, Bengt, Ola E. Dahl, Nadia Rosencher, Andreas Clemens, Stefan Hantel, Martin Feuring, Jörg Kreuzer, Michael Huo, und Richard J. Friedman. "Oral Dabigatran Etexilate Versus Enoxaparin for Venous Thromboembolism Prevention After Total Hip Arthroplasty: Pooled Analysis of Two Phase 3 Randomized Trials." Thrombosis Journal 13 (2015). https://doi.org/10.1186/s12959-015-0067-8.
MLA-Zitierstil (9. Ausg.)Eriksson, Bengt, et al. "Oral Dabigatran Etexilate Versus Enoxaparin for Venous Thromboembolism Prevention After Total Hip Arthroplasty: Pooled Analysis of Two Phase 3 Randomized Trials." Thrombosis Journal, vol. 13, 2015, https://doi.org/10.1186/s12959-015-0067-8.